In mammals TGFβ promotes hematopoietic stem cell quiescence by downregulating Akt activity and upregulating FoxO3 activity [85], and in glioblastoma cells TGFβ signaling induces Smad-FoxO transcriptional activation complexes that suppress proliferation [86]. The gene discussed is AKT1; the disease is glioblastoma.